These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23771682)

  • 1. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
    Turner AM
    BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
    Mohanka M; Khemasuwan D; Stoller JK
    Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin deficiency.
    Bals R
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
    Hurley K; Reeves EP; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S; Lin YY; He J; Rouhani FN; Brantly M; Turino GM
    COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C; Reeves EP; McElvaney NG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
    Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
    Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
    Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.
    Strange C
    Respir Care; 2018 Jun; 63(6):690-698. PubMed ID: 29794204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.